Nitric oxide pioneer donates products to help Nepal in COVID-19 crisis

By Hank Schultz contact

- Last updated on GMT

©Getty Images - FotoVoyager
©Getty Images - FotoVoyager

Related tags: nitric oxide boosters, Nitric oxide

A company founded by a nitric oxide research pioneer will donate $790,000 worth of supplements to Nepal to help combat the COVID-19 treatment crisis there.

The donation was announced by Byran Nitriceuticals, LLC, which was founded by Dr Nathan S. Bryan, PhD, who has researched nitric oxide ingredients and biological effects for more than 20 years.  The donation of 10,000 bottles of the company’s product was made possible in part by an unnamed Texas philanthropist, the company said.

Dr Bryan noted that Nepal has been especially hard hit by the global pandemic.  There are currently around 3,000 new cases each day, more than 700,000 total cases and more than 10,000 deaths in a country of only 28 million people.

Former Texas State Sen. Dan Shelley participated in the donation, saying, “I could not ignore the news stories revealing the COVID cases and deaths in Nepal. I have close friends in Nepal and believe this Nitric Oxide (NO) supplement will provide safe and effective solutions for at-risk patients to the masses, including the people of Nepal.”

Blood flow implicated in COVID-19

Dr Bryan said that as more research accumulates about COVID-19 it has become clear that maintaining adequate blood flow is a key element in the successful treatment of severe cases.

“Over the past 19 months, everything we have learned about COVID reveals that it is a disease of Nitric Oxide deficiency.  Similar to strategies of supplementing zinc, Vitamin D and Vitamin C to at-risk or infected COVID patients, we can supplement with Nitric Oxide as a means to support blood flow, circulation and normalize oxygen carrying capacity of our red blood cells,” ​Bryan said.

“We recognize the importance of Nitric Oxide in COVID and we also recognize the global need for safe and effective strategies to combat against this global pandemic, especially in regions that may not have access to same medical care as in the US,” ​he added.

Related news

Related products

show more

Related suppliers

Follow us

Products

View more

Webinars